Zante Greg's Form 4 filing
Viking Therapeutics, Inc. (VKTX) · filed Apr 3, 2023
- Accession no.
- 0001209191-23-022398
- Filed
- Apr 3, 2023
- Trade date
- Mar 30-Apr 3, 2023
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 9 non-derivative transactions and 5 derivative transactions. Open-market sales total $2.78M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Zante GregCIK 0001264949 | Officer (Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 30, 2023 | Common Stock, par value $0.00001 per share | MOption exerciseAcquired | +32,000 | $8.52 | +$272,640 | 217,057 | Direct | |
| Mar 30, 2023 | Common Stock, par value $0.00001 per share | MOption exerciseAcquired | +42,000 | $7.69 | +$322,980 | 259,057 | Direct | |
| Mar 30, 2023 | Common Stock, par value $0.00001 per share | MOption exerciseAcquired | +12,250 | $4.65 | +$56,962.5 | 271,307 | Direct | |
| Mar 30, 2023 | Common Stock, par value $0.00001 per share | MOption exerciseAcquired | +7,500 | $4.12 | +$30,900 | 278,807 | Direct | |
| Mar 30, 2023 | Common Stock, par value $0.00001 per share | SSaleDisposed | −131,029 | $17.00 | −$2,227,493 | 147,778 | Direct | |
| Apr 3, 2023 | Common Stock, par value $0.00001 per share | MOption exerciseAcquired | +30,911 | $7.77 | +$240,178.47 | 178,689 | Direct | |
| Apr 3, 2023 | Common Stock, par value $0.00001 per share | SSaleDisposed | −30,911 | $18.00 | −$556,398 | 147,778 | Direct | |
| Apr 3, 2023 | Common Stock, par value $0.00001 per share | AGrant or awardAcquired | +56,667 | $0.00 | $0 | 204,445 | Direct | |
| Apr 3, 2023 | Common Stock, par value $0.00001 per share | FTax withholdingDisposed | −55,166 | $17.57 | −$969,266.62 | 149,279 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 30, 2023 | Common Stock | MOption exerciseDisposed | −32,000 | $0.00 | $0 | 0 | Direct | |
| Mar 30, 2023 | Common Stock | MOption exerciseDisposed | −42,000 | $0.00 | $0 | 0 | Direct | |
| Mar 30, 2023 | Common Stock | MOption exerciseDisposed | −12,250 | $0.00 | $0 | 0 | Direct | |
| Mar 30, 2023 | Common Stock | MOption exerciseDisposed | −7,500 | $0.00 | $0 | 0 | Direct | |
| Apr 3, 2023 | Common Stock | MOption exerciseDisposed | −30,911 | $0.00 | $0 | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.